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OBJECTIVE—Endoplasmic reticulum stress increases macro-
phage apoptosis, contributing to the complications of atheroscle-
rosis. Insulin-resistant macrophages are more susceptible to
endoplasmic reticulum stress–associated apoptosis probably
contributing to macrophage death and necrotic core formation in
atherosclerotic plaques in type 2 diabetes. However, the molec-
ular mechanisms of increased apoptosis in insulin-resistant mac-
rophages remain unclear.
RESEARCH DESIGN AND METHODS—The studies were
performed in insulin-resistant macrophages isolated from insulin
receptor knockout or ob/ob mice. Gain- or loss-of-function ap-
proaches were used to evaluate the roles of forkhead transcrip-
tion factors (FoxOs) in endoplasmic reticulum stress–associated
macrophage apoptosis.
RESULTS—Insulin-resistant macrophages showed attenuated
Akt activation and increased nuclear localization of FoxO1
during endoplasmic reticulum stress induced by free cholesterol
loading. Overexpression of active FoxO1 or FoxO3 failed to
induce apoptosis in unchallenged macrophages but exacerbated
apoptosis in macrophages with an active endoplasmic reticulum
stress response. Conversely, macrophages with genetic knock-
outs of FoxO1, -3, and -4 were resistant to apoptosis in response
to endoplasmic reticulum stress. FoxO1 was shown by chroma-
tin immunoprecipitation and promoter expression analysis to
induce inhibitor of Bε gene expression and thereby to attenuate
the increase of nuclear p65 and nuclear factor-B activity during
endoplasmic reticulum stress, with proapoptotic and anti-inﬂam-
matory consequences.
CONCLUSIONS—Decreased Akt and increased FoxO tran-
scription factor activity during the endoplasmic reticulum stress
response leads to increased apoptosis of insulin-resistant mac-
rophages. FoxOs may have a dual cellular function, resulting in
either proapoptotic or anti-inﬂammatory effects in an endoplas-
mic reticulum stress–modulated manner. In the complex plaque
milieu, the ultimate effect is likely to be an increase in macro-
phage apoptosis, plaque inﬂammation, and destabilization.
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P
atients with type 2 diabetes have a strikingly
increased incidence of atherosclerotic cardiovas-
cular disease. In part, this reﬂects diabetic dys-
lipidemia characterized by increased VLDL and
reduced HDL levels secondary to peripheral insulin resis-
tance and hyperinsulinemia (1,2). Vascular insulin resis-
tance may also play a role in the acceleration of
atherosclerosis in diabetes. Decreased insulin signaling
and Akt activity in vascular endothelium impair vascular
nitric oxide responses and are associated with increased
expression of inﬂammatory genes, vascular cell adhesion
molecule-1, and accelerated atherosclerosis (3,4). More-
over, diabetic individuals are susceptible to complications
of atherosclerotic plaque formation, reﬂecting plaque in-
stability. Apoptosis of macrophages, smooth muscle cells,
and endothelial cells in advanced atherosclerotic lesions is
thought to lead to plaque rupture and atherothrombosis
(5). Atherosclerotic lesions from patients with type 2
diabetes showed increased areas of necrotic core and
increased numbers of apoptotic macrophages even after
normalization for total lesion area, suggesting that mac-
rophage apoptosis and resulting necrotic core formation
may speciﬁcally contribute to plaque instability in dia-
betes (5).
A variety of different processes contribute to macro-
phage apoptosis in advanced lesions, including growth
factor withdrawal, hypoxia, and oxidative and other cellu-
lar stresses. Several of these factors mediate apoptosis by
activating the cellular endoplasmic reticulum stress re-
sponse. Increased expression of C/EBP homologous pro-
tein (CHOP, also known as Ddit3/Gadd153) is a hallmark
of endoplasmic reticulum stress, and CHOP is expressed
in a subset of macrophages in advanced atherosclerotic
lesions in both humans and mice (6–8). The endoplasmic
reticulum stressors in atherosclerotic plaques include free
cholesterol (FC), 7-oxysterols, oxidized phospholipids,
and homocysteine (6,9–11). The unfolded protein re-
sponse (UPR) is an adaptive response to endoplasmic
reticulum stress that involves decreased translation of
most proteins but increased expression of a subset of
molecules involved in protein refolding or other endoplas-
mic reticulum functions (12). The UPR involves a balance
or pro- and antiapoptotic factors and only leads to apo-
ptosis when endoplasmic reticulum stress is overwhelm-
ing or accompanied by additional apoptotic stimuli.
Endoplasmic reticulum loading of free cholesterol induces
CHOP but is insufﬁcient to cause apoptosis unless accom-
panied by an additional stimulus, such as ligation of the
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DIABETES, VOL. 57, NOVEMBER 2008 2967scavenger receptor A (SRA) by modiﬁed LDL (13). The
UPR is also associated with an increase in Akt phosphor-
ylation and activity, which is thought to represent a
compensatory prosurvival mechanism (14).
Macrophages from ob/ob mice have decreased levels of
insulin receptors and show decreased phosphorylation of
insulin receptor substrate 2 in response to insulin, indicat-
ing macrophage insulin resistance (15,16). To model the
vascular effects of macrophage insulin resistance, we
transplanted bone marrow from Insr
/ mice into Ldlr
/
recipients. This was associated with a dramatic increase in
necrotic core formation, reﬂecting increased numbers of
apoptotic macrophages (14). Insr
/ macrophages
showed increased susceptibility to apoptosis induced by
loading with free cholesterol or oxidized LDL. In Insr
/
macrophages, there was a marked blunting of Akt phos-
phorylation in response to endoplasmic reticulum stress
(14). Insulin signaling leads to a variety of progrowth,
antiapoptotic responses, notably phosphorylation and nu-
clear exclusion of the closely related transcription factors
forkhead transcription factor 01(FoxO1), -3, and -4. The
goal of the present study was to evaluate the hypothesis
that decreased Akt signaling and increased activity of
FoxOs during the endoplasmic reticulum stress response
are responsible for the increased apoptotic response of
insulin-resistant macrophages.
RESEARCH DESIGN AND METHODS
LDL receptor knockout, ob/ob, and control mice were obtained from The
Jackson Laboratories (Bar Harbor, ME). Double-knockout mice were gener-
ated by crossing C57BL6J Insr
/ (14) and Ldlr
/ mice. The Ldlr
/Insr
/
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FIG. 1. Myr-Akt rescues insulin-resistant
macrophages from apoptosis. A and B:
ConA-elicited peritoneal macrophages
from Insr
/, Insr
/ (A), ob control, or
ob/ob (B) mice were transduced with ad-
enovirus containing constitutively active
myristoylated Akt (Myr-Akt) or control
LacZ at 500 MOI for 18 h. After the
transduction, macrophages were loaded
with FC for 16 h. C: Macrophages were
treated with 5 mol/l LY-294002 for 1 h
prior and together with FC loading for
16 h and then stained with annexin V and
propidium iodide for apoptosis assay.
(Please see http://dx.doi.org/10.2337/
db08-0520 for a high-quality digital repre-
sentation of this image.)
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described previously (17).
Primary macrophage culture and free cholesterol loading. Peritoneal
macrophages were harvested by peritoneal lavage 3 days after intraperitoneal
injection of concanavalin A (ConA) (6). Macrophages were maintained in
culture medium (Dulbecco’s modiﬁed Eagle’s medium supplemented with 10%
fetal bovine serum and 20% L-cell conditioned medium) until 90% conﬂuent.
Bone marrow–derived macrophages were differentiated from marrow cells by
culture in the aforementioned medium for 10–12 days. FC was loaded by
incubating cells in culture medium containing 10 g/ml ACAT inhibitor 58035
(Sigma) plus 100 g/ml acetylated LDL for the indicated time periods.
Plasmid construction. Plasmids encoding FoxO1-ADA and DNA binding–
deﬁcient (DBD) FoxO1-ADA were previously described (18). The upstream
sequence of mouse inhibitor of B( I B) ε (from 295 to 200) was ampliﬁed
from mouse genomic DNA by PCR using the following primers: 5-ACTCTC
GAGTGAATGAAGACACCACGGAAC-3 and 5-AGTAAGCTTAGGGTCCAGC
GGGATCTAACT-3 and cloned into pGL3-Basic luciferase reporter plasmid
(IBε -295-Luc). Deletion mutants were generated by standard procedures.
IBε -295TM (triple mutant)-Luc, which contains mutations in three consensus
forkhead binding motifs [AAA(C/T)A] between 295 and 159 region was
generated using the QuikChange II Site-Directed Mutagenesis kit (Stratagene).
Primer sequences are available on request.
Adenoviral vectors. Adenovirus encoding Myr-Akt (19), FoxO1-ADA (20),
control short hairpin RNA (shRNA), FoxO1 shRNA (20), and nuclear factor-B
(NF-B)–responsive reporter construct (21) were previously described.
FoxO3a-AAA was obtained from Vector BioLabs. Ampliﬁed adenoviruses
were puriﬁed with AdenoPACK100 (Sartorius) and titrated with Adeno-X
Rapid Titer Kit (BD Biosciences).
Macrophage apoptosis assay. Apoptosis assays were performed by staining
macrophages with Alexa 488- or 594-labeled annexin V and propidium iodide
using Vybrant Apoptosis Assay kit (Invitrogen). At least three separate ﬁelds
for each treatment condition were randomly selected and counted for cells
(200) positively stained for annexin V and propidium iodide and are shown
as a percentage of total cell number.
p65 NF-B localization. Nuclear and cytoplasmic proteins were extracted
using Nuclear Extraction kit (Panomics). Western blot was carried out using
p65 NF-B (F-6) from Santa Cruz Biotechnology for primary antibody.
LaminB1 (Santa Cruz Biotechnology) or nucleophosmin (Zymed Laboratories)
were used as loading controls.
FoxO1 localization. Peritoneal macrophages were cultured in Lab-Tek II
Chamber Slide System (Nalge Nunc International). For endogenous FoxO
staining, cells were ﬁxed with 2% paraformaldehyde and immunostained for
FoxO1 using a mixture of rabbit polyclonal antibodies, FoxO1 (9462; Cell
Signaling), FKHR (H-128; Santa Cruz Biotechnologies), and 3587 (22) over-
night at 4°C, each used at a dilution of 1:100. Alexa Fluor 488 goat anti-rabbit
IgG (Invitrogen) were used as secondary antibodies. Adenovirus encoding
FoxO1–green ﬂuorescent protein (GFP) was transduced in primary macro-
phages at 500 multiplicity of infection (MOI) for 16 h and incubated for
another 32 h before treatment. Nuclei were stained with Hoechst (Invitrogen)
for 10 min.
Chromatin immunoprecipitation assays. Chromatin immunoprecipitation
(ChIP) assay was performed with ChIP Assay kit (Millipore). After plasmid
transfection, 6  10
6 RAW 264.7 cells were ﬁxed with 1% formaldehyde for 30
min at room temperature. Cell lysate was sonicated for 3 min at 4°C. After
preclearing with 100 l salmon sperm DNA/protein A-Sepharose, protein
lysate was immunoprecipitated with 2 g anti-FKHR antibody (Santa Cruz
Biotechnology) or an equal amount of normal rabbit IgG for 16 h at 4°C. The
antibody-protein-DNA complexes were collected with 40 l salmon sperm
DNA/protein A-Sepharose. After releasing crosslink, puriﬁed DNA was sub-
jected to PCR using the following primers: 5-TGAATGAAGACACCACGGAA
C-3 and 5-GCTTGCGTAGGCAGGGAGTC-3 to amplify the 295 to 130
region of the mouse IB promoter.
Statistical analysis. Results are expressed as means  SD, and statistical
signiﬁcance of differences was evaluated with Student’s t test.
RESULTS
Myr-Akt rescues the apoptotic defect in Insr
/ and
ob/ob macrophages. We previously showed reduced in-
duction of Akt phosphorylation during the UPR in Insr
/
macrophages compared with Insr
/ macrophages. To
ascertain whether this might contribute to enhanced apo-
ptosis, we used adenovirus to overexpress a constitutively
active form of Akt (Myr-Akt). FC loading using AcLDL an
ACAT inhibitor (58035) led to increased apoptosis in
Insr
/ cells compared with Insr
/ cells, as reported
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FIG. 2. FoxO is preferentially localized to the nucleus in FC-loaded or insulin-resistant macrophages. A and C: ConA-elicited peritoneal
macrophages from Insr
/, Insr
/, ob control, or ob/ob mice were transduced with adenovirus encoding FoxO1-GFP and treated with FC for 6 h,
and then the GFP signal localization was analyzed. A: The representative images of localization in FoxO1-GFP transduced macrophages are
shown. Arrows indicate FoxO localization in nucleus. B: For endogenous FoxO staining, cells were ﬁxed after6ho fF Cloading and stained with
antibodies against FoxO1 and Hoechst dye. Percentage of nuclear FoxO-positive cells to total cell number (B) or to GFP-positive cells (randomly
counted at least 100 GFP-positive cells) (A and C) was shown in ﬁgures. (Please see http://dx.doi.org/10.2337/db08-0520 for a high-quality digital
representation of this image.)
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reduction in apoptosis in response to FC loading in both
sets of cells and virtually eliminated the difference be-
tween Insr
/ and Insr
/ cells (Fig. 1A). Given that
transduction efﬁciency of adenovirus was 	60%, this
indicates a substantial reversal of the effect of FC
loading and insulin receptor deﬁciency on apoptosis.
Myr-Akt expression did not affect the uptake of AcLDL
or FC accumulation in macrophages (not shown). To
assess whether similar responses could be observed in
cells with less severe defects in insulin signaling, we
also audited the antiapoptotic impact of activated Akt in
insulin-resistant ob/ob macrophages. Enhanced apopto-
sis in response to FC loading was also seen in ob/ob
macrophages, and this response was partly rescued by
Myr-Akt overexpression (Fig. 1B). To reinforce the
relevance of the phosphatidylinositol 3-kinase-Akt sig-
naling axis in this physiological process, we assessed
the impact of inhibition of endogenous Akt activity in
FC-loaded macrophages, using the phosphatidylinositol
3-kinase inhibitor LY-294002. This treatment resulted in
a pronounced increase in apoptosis in FC-loaded wild-
type macrophages (Fig. 1C). These data suggest that
induction of Akt activity during FC-induced endo-
plasmic reticulum stress provides an antiapoptotic func-
tion that is otherwise impaired in insulin-resistant
macrophages.
FoxO1 and FoxO3 promote macrophage apoptosis
during the UPR. Insulin signaling via phosphatidylinosi-
tol 3-kinase leads to Akt-mediated phosphorylation of
FoxO1 and FoxO3 on serine residues, causing nuclear
exclusion and loss of transcriptional activity (22). Addi-
tionally, FC loading of macrophages leads to activation of
Jun NH2-terminal kinase (JNK), and in other settings, JNK
can phosphorylate related FoxOs (FoxO4) on different
amino acids, resulting in nuclear localization and activa-
tion (23,24). We observed increased nuclear FoxO1 as a
result of FC loading or insulin receptor deﬁciency and an
additive effect of FC loading and insulin receptor deﬁ-
ciency in Insr
/ macrophages (Fig. 2A shows FoxO1-
GFP; Fig. 2B shows endogenous nuclear FoxO1). ob/ob
macrophages also showed increased nuclear FoxO1 com-
pared with wild-type macrophages, and again, FC loading
further increased levels of nuclear FoxO1 (Fig. 2C). Thus,
both decreased insulin signaling and FC-induced endoplas-
mic reticulum stress are associated with increased nuclear
FoxO1.
To evaluate the effect of constitutively nuclear forms
of FoxOs on apoptosis, we transduced macrophages
with FoxO1 or FoxO3 in which Akt target serine resi-
dues had been mutated to alanine or aspartic acid
(FoxO1-ADA and FoxO3-AAA). Whereas in control mac-
rophages, there was only a slight increase in apoptosis,
the constitutively active FoxOs resulted in a robust
AB
D C
0
10
20
30
A
p
o
p
t
o
t
i
c
 
c
e
l
l
s
 
(
%
)
Adenovirus
(MOI)
(-) LacZ
1000
FoxO1-
ADA
500
FoxO1-
ADA
1000
FC(-)
FC(+)
p=0.03
p=0.05
0
4
8
12
16
Adenovirus
(MOI)
GFP
500
FoxO3a-
AAA
500
(-)
A
p
o
p
t
o
t
i
c
 
c
e
l
l
s
 
(
%
)
FC(-)
FC(+)
p>0.001
0
5
10
15
20
25
30
A
p
o
p
t
o
t
i
c
 
c
e
l
l
s
 
(
%
)
 
Insr
Insr
Thapsigargin (+) (+)
(+)
p=0.001
Ac-LDL
Insr+/-
Insr-/-
p=0.001
0
4
8
12
16
Z c a L s u r i v o n e d A
Thapsigargin
A
p
o
p
t
o
t
i
c
 
c
e
l
l
s
 
(
%
)
NS
p<0.001
LacZ
FoxO1-
ADA
FoxO1-
ADA
(-) (-)
(-) (-)
FIG. 3. FoxOs enhance endoplasmic reticulum–stressed macrophage apoptosis. ConA-elicited peritoneal macrophages were transducted with
adenovirus containing constitutively active FoxO1 (FoxO1-ADA), FoxO3 (FoxO3-AAA), or controls at 500 MOI for 18 h. Macrophages were
loaded with FC (A and B) or treated with 0.5 mol/l thapsigargin (D) for 16 h. ConA-elicited macrophages from Insr
/ control or Insr
/ mice
were treated with 0.25 mol/l thapsigargin and/or 50 g/ml Ac-LDL for 30 h (C) and stained with annexin V and propidium iodide for apoptosis
assay.
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3A and B). These ﬁndings suggest that FoxO1 and
FoxO3 have a major role in promoting apoptosis in cells
undergoing the UPR in response to FC loading but not in
unstressed cells. To determine whether this was a
general feature of the endoplasmic reticulum stress
response, we subjected macrophages to a different form
of endoplasmic reticulum stress by treating them with
thapsigargin, an agent that inhibits the endoplasmic
reticulum Ca
2 pump sarcoplasmic/endoplasmic reticu-
lum calcium ATPase (SERCA). First, we showed that
thapsigargin caused an increased amount of apoptosis
in Insr
/ relative to Insr
/ cells, consistent with our
previous demonstration that Insr
/ cells are more
susceptible to apoptosis induced by a variety of endo-
plasmic reticulum stress responses (Fig. 3C). Second,
we showed a dramatic increase in apoptosis in cells
treated with both FoxO1-ADA and thapsigargin but not
in cells treated with either alone (Fig. 3D).
To evaluate further the role of FoxOs in apoptotic
responses, we assessed the impact of FoxO1 or FoxO3
knockdown via shRNA or siRNA (small interfering RNA)
approaches, respectively. The knockdown was 	50% ef-
fective on an mRNA level for each transcription factor
(supplementary Fig. S1A, which is available in an online
appendix at http://dx.doi.org/10.2337/db08-0520). There
was a signiﬁcant reduction of apoptosis with knockdown
of either transcription factor in FC-loaded Insr
/ and
Insr
/ cells. The combined knockdown of FoxO1 and
FoxO3 caused a further reduction in apoptosis to a similar
ﬁnal level in Insr
/ and Insr
/ cells (supplementary
Fig. S1B). Comparable results were obtained in ob/ob
macrophages (supplementary Fig. S1C). These ﬁndings
indicate that FoxO1 and FoxO3 are involved in the apo-
ptosis brought about by FC loading and mediate the
enhanced apoptotic response observed in Insr
/ and
ob/ob macrophages.
Macrophages express all three of the related FoxO
isoforms, FoxO1, -3, and -4. To conﬁrm the role of endog-
enous FoxOs in enhancing an apoptotic response during
endoplasmic reticulum stress, we evaluated the response
of primary peritoneal macrophages and bone marrow–
derived macrophages with combined knockouts of FoxO1/
3/4, obtained by injecting polyinosine-polycytidylic acid
into the Mx-Cre transgenic mice containing ﬂoxed trans-
genes for each of the three FoxOs (17). Efﬁcient knockout
of all three FoxOs in bone marrow and peritoneal macro-
phages was conﬁrmed by PCR (supplementary Fig. S2).
This genetic system showed a markedly decreased apopto-
tic response of the triple-knockout macrophages in re-
sponse to FC loading in both types of macrophages (Fig.
4A and B).
Mechanisms of FoxO-induced apoptosis during endo-
plasmic reticulum stress. We next considered three
potential mechanisms to explain the effect of active
FoxOs: 1) induction of UPR genes, 2) enhancement of the
effects of SRA ligation in the context of the UPR (25), and
3) modiﬁcation of the apoptotic response to the UPR.
Previous studies have shown that FoxO1 induces CHOP
expression during differentiation of preadipocytes into
adipocytes (26), suggesting that FoxO1-ADA could be
enhancing apoptosis by increasing the UPR. However,
CHOP mRNA and protein were not further induced by
FoxO1-ADA or FoxO3-AAA in control, FC-loaded, or thap-
sigargin-treated macrophages (supplementary Fig. S3A–C;
data not shown). A combination of UPR induction and
ligation of the SRA (e.g., by the SRA ligand fucoidan) is
required to see an apoptotic response in FC-loaded mac-
rophages, and this response is much more prominent in
Insr
/ than in Insr
/ macrophages (25). If FoxO1-ADA
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incubation with Ac-LDL  58035, it would be anticipated
that fucoidan would increase apoptosis in cells expressing
FoxO1-ADA. However, the combination of FoxO1-ADA
and fucoidan did not increase apoptosis (supplementary
Fig. S3D). Moreover, in thapsigargin-treated Insr
/ cells,
addition of the SRA ligand Ac-LDL did not lead to a further
increase in the level of apoptosis beyond that observed in
Insr
/ cells (Fig. 3C). Together, the ﬁndings tend to
exclude mechanisms 1 and 2.
Insr
/ and ob/ob macrophages display increased
IB and decreased nuclear p65 during the UPR. We
next considered the possibility that FoxOs were modifying
the response to the UPR in a way that led to increased
apoptosis (mechanism 3). The UPR leads to an increase in
nuclear p65 and NF-B activity and induction of antiapop-
totic genes (27,28). FC loading also leads to increased p65
and NF-B activity (29), and blocking this response by
overexpressing the IB
 super-repressor resulted in in-
creased apoptosis (supplementary Fig. S4), similar to
previous results (30,31). The induction of nuclear p65 (Fig.
5A) and NF-B activity (Fig. 5B) during FC loading was
attenuated in Insr
/ cells, and NF-B activity was also
reduced in FC-loaded ob/ob macrophages (supplementary
Fig. S5).
FoxO3 knockout mice show lymphoid hyperplasia and
autoimmune phenomena reﬂecting expansion of T-cell
populations (32), reﬂecting prolonged lymphocyte survival
related to increased nuclear p65 and NF-B activity. The
increase in nuclear p65 was explained by a decrease in the
mRNA and protein of IB and IBε (32). We found an
increased level of IBε but not IB
 or IB in Insr
/
cells in the basal state and during the early response (6 h)
to FC loading (Fig. 5C and D). IB mRNA was similarly
increased in Insr
/ cells (Fig. 5E). After 10 h of FC
loading, the differential response of IBε was eliminated
because of a more prominent increase of IBε in Insr
/
cells than in Insr
/ cells, likely reﬂecting the more robust
increase of nuclear p65 in Insr
/ cells (Fig. 5A) and the
subsequent feedback induction of IBε (33,34). ob/ob
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FIG. 5. Attenuated NF-B activity and increased IB in Insr
/ macrophages. ConA-elicited peritoneal macrophages from Insr
/ and Insr
/
mice were loaded with FC for the indicated hours. Cells were lysed and subjected to nuclear fractionation. A and C: Nuclear (15 g) (A) and
cytoplasmic (50 g) (B) protein were analyzed by SDS-PAGE and immunoblotting for p65 NF-B, the nuclear marker LaminB1, IBs, and the
cytoplasmic marker -actin. Total RNA was extracted from ConA-elicited peritoneal macrophages from Insr
/ and Insr
/ mice for quantitative
real-time PCR. E: Gene expression was normalized to -actin expression. D: Data were quantiﬁed from three independent Western blot
experiments. ConA-elicited peritoneal macrophages were transduced with adenovirus containing NF-B–responsive luciferase reporter construct
and LacZ at 500 and 100 MOI, respectively, for 18 h. After FC loading for the indicated hours, cells were lysed and subjected to luciferase assay.
B: Reporter luciferase activity was normalized to transduction efﬁciency evaluated by -galactosidase activity per microgram protein.
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plementary Fig. S5B and C). Because IBs bind p65 in the
cytosol (33–36), these ﬁndings offer a plausible explana-
tion for the decreased nuclear p65 and NF-B activity seen
in Insr
/ and ob/ob macrophages.
FoxO1 binds and activates the IB promoter. We
next determined whether the increase in IB gene ex-
pression in Insr
/ cells could be linked to increased
nuclear FoxOs. Consistent with this possibility, overex-
pression of constitutively active FoxO1 or FoxO3 resulted
in increased IB mRNA and protein levels without
changes in IB
 or IB isoforms and a decrease in the
nuclear localization of p65 in response to FC loading (Fig.
6A–D). The increase in IBε was seen in non–FC-loaded
macrophages but not after 10 h of FC loading, similar to
the loss of the differential response of Insr
/ and Insr
/
macrophages after 10 h of FC loading (Figs. 6C and 5C).
Knockdown of endogenous FoxO1 by shRNA resulted in
decreased expression of IB mRNA (Fig. 6E). These
experiments suggest that increased IBε levels reﬂect
increased activity of FoxOs and lead to decreased nuclear
p65 in Insr
/ macrophages.
To see whether the IB gene might be a direct target of
FoxOs, we overexpressed FoxO1-ADA and FoxO3-AAA in
cells transfected with an IB promoter-luciferase re-
porter gene. A construct containing 295 bp of upstream
sequence showed transactivation by FoxOs, whereas a
construct containing only 159 bp of upstream sequence did
not (Fig. 7A and B). ChIP analysis revealed occupancy of
the 159 to 295 bp region of the IB promoter by
FoxO1 (Fig. 7C, top panel). We identiﬁed three putative
FoxO binding core sequences [AAA(C/T)A] in this region,
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FIG. 6. FoxOs decrease FC-induced NF-B nuclear translocation and increase IB. ConA-elicited peritoneal macrophages were transduced with
adenovirus encoding FoxO1-ADA or FoxO3-AAA for 18 h followed by loading with FC for 10 h. Cells were lysed and subjected to nuclear
fractionation. A and C: Nuclear (15 g) and cytoplasmic (50 g) proteins were analyzed by SDS-PAGE and immunoblotting for p65 NF-B, the
nuclear marker nucleophosmin, IBs, and the cytoplasmic marker -actin. B: Data were quantiﬁed from three independent Western blot
experiments. Total RNA was extracted for quantitative PCR from the macrophages transducted with adenovirus encoding FoxO-ADA or speciﬁc
shRNA for FoxO1 (shFoxO) after 18 or 36 h of transduction, respectively. D and E: Gene expression was normalized to -actin expression.
(Please see http://dx.doi.org/10.2337/db08-0520 for a high-quality digital representation of this image.)
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mans, and nonhuman primates. However, using a DBD
FoxO1 mutant, we still obtained transactivation of the
IB promoter, consistent with the conclusion that FoxO1
activated IB transcription without direct DNA binding
(Fig. 7D) (18,37,38). Moreover, the ChIP analysis showed
binding of FoxO1 to the IB promoter containing muta-
tions in all three potential FoxO binding sites (Fig. 7C,
bottom panel). Thus, FoxO1 transactivates the proximal
IB promoter likely by interacting with other molecules
that directly bind the DNA in the 159 to 295 region.
These ﬁndings are consistent with previous studies show-
ing that a subset of FoxO1/3 target genes is induced
without direct binding of FoxOs to target promoters
(18,37,38).
Decreased expression of inﬂammatory and antiapop-
totic genes in FC-loaded Insr
/ macrophages. Previ-
ous reports have suggested either increased apoptosis or
decreased inﬂammatory gene expression in Insr
/ mac-
rophages (14,39). The ﬁnding of reduced NF-B activity in
these cells suggested a common mechanism to explain
both increased apoptosis and reduced inﬂammatory re-
sponses. Consistent with this idea, we found decreased
expression of several antiapoptotic genes (known targets
of NF-B) and some but not all proinﬂammatory genes in
Insr
/ cells treated with FC loading (Fig. 8).
DISCUSSION
Our ﬁndings are consistent with the hypothesis that a
blunted Akt response in insulin-resistant macrophages
promotes apoptosis during the endoplasmic reticulum
stress response and show that a major underlying
mechanism involves increased activity of FoxO tran-
scription factors. FoxO1 binds the promoter and in-
duces expression of IBε , blunting the p65/NF-B
response to endoplasmic reticulum stress, with pro-
apoptotic and anti-inﬂammatory consequences. These
studies are likely relevant to the mechanisms of in-
creased macrophage apoptosis, necrotic core forma-
tion, and plaque destabilization in type 2 diabetic
individuals (5) and suggest that insulin-sensitizing
agents, such as peroxisome proliferator–activated re-
ceptor- agonists that reduce macrophage insulin re-
sistance in vivo (15), could have beneﬁcial effects
in diabetic at herosclerosis by promoting plaque
stabilization.
The closely related FoxO transcription factors FoxO1,
-3, and -4 have a variety of different roles in modulating
cell cycle control, apoptosis, and antioxidant responses
with substantial redundancy and variable effects depen-
dent on cell type and context (40). A recent study has
revealed fundamental and overlapping roles of FoxO1,
-3, and -4 in cell cycle control, induction of antioxidant
molecules, and protection from apoptosis in hematopoi-
etic stem cells (41). In contrast, in the present study,
macrophages with knockout of all three FoxOs showed
increased survival during endoplasmic reticulum stress
induced by FC loading or growth factor withdrawal.
Overexpression of FoxOs in various immortalized cell
lines has been shown to induce apoptosis, and FoxO1
FIG. 7. FoxO upregulates IB transactivity by indirect interaction. RAW 264.7 cells were cultured in a 24-well plate and cotransfected with
luciferase reporter plasmids (control pGL3-basic, IB-295, IB-159, or IB-295TM [triple mutant] [0.8 g/well] with pRL-CMV Renilla
luciferase vector [12.5 ng/well]) and FoxO1-ADA, DBD-FoxO1-ADA plasmid (0.8 g/well), or FoxO3-AAA adenovirus (500 MOI) with
Lipofectamine transfection reagent and cultured for 18 h. A, B, and D: Cells were lysed for luciferase activity measurement. The reporter
luciferase activity was normalized to cotransfected Renilla luciferase activity. For ChIP assay, 6  10
6 of RAW 264.7 cells were cultured in a 10-cm
dish. Cells were cotransfected with 6.4 gI B-295 or IB-295TM and 6.4 g control or FoxO1-ADA plasmid with Lipofectamine transfection
reagent and cultured for 18 h. C: Cells were then ﬁxed and subjected to ChIP assay.
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variety of proapoptotic factors, such as Bim, Fas-ligand,
and TRAIL (tumor necrosis factor–related apoptosis-
inducing ligand). However, increased expression of
these molecules did not appear to be involved in the
increased apoptosis shown by primary cultures of
Insr
/ macrophages (C.P.L., unpublished data). CHOP
induction of Bim increases apoptosis in response to the
UPR in a variety of cell types, including peritoneal
macrophages (42). Measurements of Bim mRNA and
protein showed increased expression in response to FC
loading, but this response was not increased further in
Insr
/ macrophages (supplementary Fig. S6). Impor-
tantly, although FoxO1/3 overexpression or knockdown
had little effect on macrophage apoptosis in the basal
condition, there were major effects during the endoplas-
mic reticulum stress response, deﬁning a physiological
role of these transcription factors in modulating macro-
phage apoptosis as part of the UPR. Thus, our ﬁndings
suggest that the outcome of FoxO-dependent transcrip-
tion is critically dependent on the local context and that
the deﬁnition of FoxO proteins as pro- or antiapoptotic
is an oversimpliﬁcation.
At least a part of the role of FoxOs in promoting
apoptosis during endoplasmic reticulum stress involved an
attenuation of the increased NF-B response that is char-
acteristic of the UPR and has an antiapoptotic function in
this context (43). The mechanism of increased NF-B
activity during the UPR is not well understood (12).
However, the blunting of this response in Insr
/ cells
appears to involve a speciﬁc increase in levels of IBε that
likely retains p65 in the cytoplasm. Our studies establish
the underlying molecular mechanism to be transactivation
of the proximal IB promoter via an indirect binding of
FoxO1/3. However, this is not necessarily the only mech-
anism by which FoxOs inﬂuence apoptosis during the
endoplasmic reticulum stress response, and this area
warrants additional investigation.
Our ﬁndings are likely relevant to the increased compli-
cations of atherosclerosis suffered by diabetic individuals.
Increased numbers of apoptotic macrophages associated
with large necrotic cores and thin caps are characteristic
of unstable plaques (44,45), and unstable plaques show
evidence of increased endoplasmic reticulum stress re-
sponses (7). A number of different potential endoplasmic
reticulum stressors, including an increased content of free
cholesterol, are likely relevant in advanced plaques
(45,46). Although most of our studies were performed
using the FC loading method to induce apoptosis, the
increase in apoptosis of insulin-resistant macrophages
during the endoplasmic reticulum stress response appears
to be generic, whether induced by FC loading, oxidized
LDL, thapsigargin, or growth factor withdrawal (14), and
thus is likely relevant to increased atherosclerotic com-
plications in diabetic individuals. Interestingly, admini-
stration of an ACAT (acyl-coenzyme A: cholesterol acyl-
transferase) inhibitor (pactimibe) to humans led to a
worsening of coronary atherosclerosis, especially in dia-
betic patients and subjects with BMI 30 (47), suggesting
direct relevance of mechanisms deﬁned here to diabetic
atherosclerosis.
Diminished levels of nuclear p65 and NF-B activity
observed in Insr
/ cells during the endoplasmic reticu-
lum stress response were associated with both increased
apoptosis and decreased expression of some inﬂammatory
genes, reﬂecting the well-known role of NF-B in inducing
these genes. This could perhaps explain previous ﬁndings
of both increased apoptosis and decreased inﬂammation
in different studies involving insulin receptor–deﬁcient
bone marrow cells in murine atherosclerosis models
(14,39). However, in the complex milieu of advanced
atherosclerotic plaques, it is likely that increased apopto-
sis of macrophages is associated with a clearance defect of
apoptotic cells, leading to postapoptotic necrosis and
inﬂammatory changes (45). Also, it is notable that in the
basal state, Insr
/ macrophages showed increased ex-
pression of a number of different inﬂammatory genes (Fig.
8). Overall, our studies suggest that insulin-resistant mac-
rophages are more likely to undergo apoptosis and to
promote plaque inﬂammation.
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